1. Home
  2. KLTO vs INGM Comparison

KLTO vs INGM Comparison

Compare KLTO & INGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTO
  • INGM
  • Stock Information
  • Founded
  • KLTO 2019
  • INGM 1979
  • Country
  • KLTO United States
  • INGM United States
  • Employees
  • KLTO N/A
  • INGM N/A
  • Industry
  • KLTO
  • INGM
  • Sector
  • KLTO
  • INGM
  • Exchange
  • KLTO NYSE
  • INGM NYSE
  • Market Cap
  • KLTO 5.9M
  • INGM N/A
  • IPO Year
  • KLTO N/A
  • INGM 2024
  • Fundamental
  • Price
  • KLTO $1.00
  • INGM $20.71
  • Analyst Decision
  • KLTO
  • INGM Strong Buy
  • Analyst Count
  • KLTO 0
  • INGM 14
  • Target Price
  • KLTO N/A
  • INGM $25.69
  • AVG Volume (30 Days)
  • KLTO 91.0M
  • INGM 341.0K
  • Earning Date
  • KLTO 08-15-2025
  • INGM 08-15-2025
  • Dividend Yield
  • KLTO N/A
  • INGM 1.47%
  • EPS Growth
  • KLTO N/A
  • INGM N/A
  • EPS
  • KLTO N/A
  • INGM 1.25
  • Revenue
  • KLTO N/A
  • INGM $48,929,580,000.00
  • Revenue This Year
  • KLTO N/A
  • INGM $6.50
  • Revenue Next Year
  • KLTO N/A
  • INGM $3.11
  • P/E Ratio
  • KLTO N/A
  • INGM $16.62
  • Revenue Growth
  • KLTO N/A
  • INGM 2.35
  • 52 Week Low
  • KLTO $0.11
  • INGM $14.25
  • 52 Week High
  • KLTO $3.91
  • INGM $25.69
  • Technical
  • Relative Strength Index (RSI)
  • KLTO N/A
  • INGM N/A
  • Support Level
  • KLTO N/A
  • INGM N/A
  • Resistance Level
  • KLTO N/A
  • INGM N/A
  • Average True Range (ATR)
  • KLTO 0.00
  • INGM 0.00
  • MACD
  • KLTO 0.00
  • INGM 0.00
  • Stochastic Oscillator
  • KLTO 0.00
  • INGM 0.00

About KLTO KLOTHO NEUROSCIENCES INC

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

Share on Social Networks: